🔓 Unlock the full profile of Mark Barrett (Madrigal Pharmaceuticals), including verified contact details, financial insights, and professional associations.
See Mark Barrett Full Profile 💼 Explore Live Investment DealsFrom IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: mar*****@mad******.com
Mobile: 93217*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Mark Barrett is a biopharma executive currently based in Cambridge, Massachusetts, holding key roles as a Board member, Founder, and Entrepreneur.
- As of January 2024, Mark Barrett will assume the position of Biopharma Executive at Madrigal Pharmaceuticals, a rapidly growing firm in the pharmaceutical industry.
- From 2018 to 2023, Mark Barrett served as the Founder, CEO, and Board member of Lassen Therapeutics, guiding the company through foundational growth and strategic development.
- Previously, Mark Barrett was an Entrepreneur-in-Residence at Frazier Healthcare Partners, where contributions focused on identifying and developing innovative healthcare solutions and investment opportunities.
- Mark Barrett played a critical role as the Global Head of Strategy & Business Development at Genzyme, a Sanofi company, where significant inroads were made in the rare disease treatment space.
- Mark Barrett's leadership at Johnson & Johnson involved pivotal roles in transactions and strategic development, enhancing partnerships and product innovation.
- Mark Barrett's early career included impactful research positions at leading institutions such as Harvard Medical School and Duke University Health System, laying the groundwork for a robust understanding of biomedical research.
- Madrigal Pharmaceuticals, under Mark Barrett's impending leadership, is poised for continued innovation in developing treatments, as reflected in its substantial market capitalization of approximately $6.7 billion.
- Mark Barrett's extensive career reflects a consistent focus on business development, strategy, and innovation in the biopharma sector, marking significant contributions to each organization associated with.